While there was a clear trend in the other groups, there were two outliers with higher RNA load in each of the groups treated via the intranasal route.
← all excerpts
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19.
1
—
—